353 related articles for article (PubMed ID: 18361400)
21. Body mass index: a marker for significant colorectal neoplasia in a screening population.
Anderson JC; Messina CR; Dakhllalah F; Abraham B; Alpern Z; Martin C; Hubbard PM; Grimson R; Shaw RD
J Clin Gastroenterol; 2007 Mar; 41(3):285-90. PubMed ID: 17426468
[TBL] [Abstract][Full Text] [Related]
22. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
23. Updated recommendations for client- and provider-oriented interventions to increase breast, cervical, and colorectal cancer screening.
Community Preventive Services Task Force
Am J Prev Med; 2012 Jul; 43(1):92-6. PubMed ID: 22704753
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of messages for breast and cervical cancer screening.
Jibaja-Weiss ML; Volk RJ; Smith QW; Holcomb JD; Kingery P
J Health Care Poor Underserved; 2005 Feb; 16(1):42-52. PubMed ID: 15741708
[TBL] [Abstract][Full Text] [Related]
25. Inequalities in breast and cervical cancer screening among urban Mexican women.
Couture MC; Nguyen CT; Alvarado BE; Velasquez LD; Zunzunegui MV
Prev Med; 2008 Nov; 47(5):471-6. PubMed ID: 18675296
[TBL] [Abstract][Full Text] [Related]
26. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
[TBL] [Abstract][Full Text] [Related]
27. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
28. Obesity and prognosis of breast cancer.
Carmichael AR
Obes Rev; 2006 Nov; 7(4):333-40. PubMed ID: 17038127
[TBL] [Abstract][Full Text] [Related]
29. [Cancer screening programme in health care workers].
Pisati G; Cerri S; Marinelli M; Tedeschi B; Valsecchi E
G Ital Med Lav Ergon; 2011; 33(2 Suppl):57-60. PubMed ID: 22187927
[TBL] [Abstract][Full Text] [Related]
30. Cancer screening - pros, cons, choice, and the patient.
Trevena L
Aust Fam Physician; 2009 Apr; 38(4):188-92. PubMed ID: 19350066
[TBL] [Abstract][Full Text] [Related]
31. Screening for the major malignancies affecting women: current guidelines.
Paley PJ
Am J Obstet Gynecol; 2001 Apr; 184(5):1021-30. PubMed ID: 11303215
[TBL] [Abstract][Full Text] [Related]
32. Cancer screening in the primary care setting: the role of the primary care physician in screening for breast, cervical, colorectal, lung, ovarian, and prostate cancers.
Miser WF
Prim Care; 2007 Mar; 34(1):137-67. PubMed ID: 17481991
[No Abstract] [Full Text] [Related]
33. Role of early diagnosis and screening; biomarkers.
Miller AB
Cancer Detect Prev; 1991; 15(1):21-6. PubMed ID: 2044070
[TBL] [Abstract][Full Text] [Related]
34. Adherence to cervical and breast cancer programs is crucial to improving screening performance.
Mauad EC; Nicolau SM; Moreira LF; Haikel RL; Longatto-Filho A; Baracat EC
Rural Remote Health; 2009; 9(3):1241. PubMed ID: 19778158
[TBL] [Abstract][Full Text] [Related]
35. Who receives, benefits from and is harmed by cervical and breast cancer screening among Hong Kong Chinese?
Leung GM; Woo PP; Cowling BJ; Tsang CS; Cheung AN; Ngan HY; Galbraith K; Lam TH
J Public Health (Oxf); 2008 Sep; 30(3):282-92. PubMed ID: 18482996
[TBL] [Abstract][Full Text] [Related]
36. Determinants of compliance in a cluster randomised controlled trial on screening of breast and cervix cancer in Mumbai, India. 1. Compliance to screening.
Dinshaw K; Mishra G; Shastri S; Badwe R; Kerkar R; Ramani S; Thakur M; Uplap P; Kakade A; Gupta S; Ganesh B
Oncology; 2007; 73(3-4):145-53. PubMed ID: 18408401
[TBL] [Abstract][Full Text] [Related]
37. [Screening for cancer].
Bjørge T; Tropé CG; Engeland A
Tidsskr Nor Laegeforen; 1999 Mar; 119(8):1129-36. PubMed ID: 10228417
[TBL] [Abstract][Full Text] [Related]
38. Determinants of compliance in a cluster randomised controlled trial on screening of breast and cervix cancer in mumbai, India. 2. Compliance to referral and treatment.
Dinshaw K; Mishra G; Shastri S; Badwe R; Kerkar R; Ramani S; Thakur M; Uplap P; Kakade A; Gupta S; Ganesh B
Oncology; 2007; 73(3-4):154-61. PubMed ID: 18408402
[TBL] [Abstract][Full Text] [Related]
39. [Epidemiology of colorectal cancer].
Becker N
Radiologe; 2003 Feb; 43(2):98-104. PubMed ID: 12624666
[TBL] [Abstract][Full Text] [Related]
40. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.
Smith RA; Cokkinides V; Brawley OW
CA Cancer J Clin; 2009; 59(1):27-41. PubMed ID: 19147867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
